An observational study to investigate patient-reported satisfaction with apixaban when switched from warfarin in Japanese NVAF patients (AGAIN study)
Phase of Trial: Phase IV
Latest Information Update: 14 Mar 2017
At a glance
- Drugs Apixaban (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- Acronyms AGAIN
- 13 Mar 2017 Status changed from recruiting to completed.
- 30 Oct 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 14 Sep 2015 New trial record